エイズ対策政策研究事業
（○：委員長）
| ○ | 鎌倉 光宏 | 慶應義塾大学 名誉教授 | |
| 感染症学、公衆衛生学、疫学 | |||
| The status and trends of HIV/AIDS epidemics in Asia and the Pacific; Current Topics of Infectious Diseases in Japan and Asia. Kamakura M. Springer(2010) |
|||
| Risk of Bronchioalveolar Carcinoma in Patients with Human T-cell Lymphotropic Virus Type1 (HTLV-1). Nomori H., Mori T.,Iyama K., Okamoto T., Kamakura M. Annals of Thoracic and Cardiovascular Surgery 2011 17(1), 19-23 |
|||
| The Current Status and Trends of HIV Infection in Japan. Kamakura M. The Journal of AIDS Research 2015 17(2),78-81 |
|||
| 岩本 愛吉 | 国立研究開発法人日本医療研究開発機構 研究開発統括推進室長 | ||
| HIV感染症、感染症内科、ウイルス学 | |||
| The HIV Cascade: Japanese Perspective. Iwamoto, A., Taira, R., Yokomaku, Y., Koibuchi, T., Rahman, M., Izumi, Y. and Tadokoro, K. PLoS ONE 12(3); e0174360. https://dx.doi.org//10.1371/journal.pone.0174360. (Published on March 20, 2017). |
|||
| Rapid HIV-1 disease progression in individuals infected with a virus adapted to its host population. Katoh, J., Kawana-Tachikawa, A., Shimizu, A., Zhu, D., Han, C., Nakamura, H., Koga, M., Kikuchi, T., Adachi, E., Koibuchi, T., Gao, G.F., Brumme, Z.L.,and Iwamoto, A. PLoS ONE 11 (3): e0150397. Doi:10.1371/journal.pone.0150397. (Published on March 8, 2016) |
|||
| Switching and emergence of CTL epitopes in HIV-1 infection. Han, C., Kawana-Tachikawa, A., Shimizu, A., Zhu, D., Nakamura, H., Adachi, E., Kikuchi, T., Koga, M., Koibuchi, T., Gao, GF., Sato, Y., Yamagata, A., Martin, E., Fukai, S., Brumme,ZL.,and Iwamoto, A. Retrovirology 11:38,2014. doi:10.1186/1742-4690-11-38, 2014. (Published on May 21, 2014). |
|||
| 髙松 純樹 | 日本赤十字社東海北陸ブロック血液センター 相談役 | ||
| 血液内科、輸血後感染症、血液凝固学 | |||
| Effects of HAART on hepatitis C, hepatitis G, and TT virus in multiplycoinfected HIV-positive patients with haemophilia. Takamatsu J, Toyoda H, Fukuda Y, Nakano I, Yokozaki S, Hayashi K, Saito H. Haemophilia. 2001 Nov;7(6):575-81 |
|||
| GB virus C and mortality from HIV infection. Takamatsu J, Toyoda H, Fukuda Y. N Engl J Med. 2002 Jan 31;346(5):377-9 |
|||
| Immunologic dynamics in hemophiliac patients infected with hepatitis C virus and human immunodeficiency virus: influence of antiretroviral therapy. Yokozaki S, Takamatsu J, Nakano I, Katano Y, Toyoda H, Hayashi K, Hayakawa T, Fukuda Y. Blood. 2000 Dec 15;96(13):4293-9. |
|||
| 宮田 一雄 | 公益財団法人エイズ予防財団 理事 | ||
| 情報啓発 | |||
| NO TIME TO LOSE （ノー・タイム・トゥ・ルーズ）― エボラとエイズと国際政治. ピーター・ピオット（宮田 一雄・樽井 正義・大村 朋子訳）. 慶應義塾大学出版会 2015年 |
|||
| 新エイズ予防指針と私たち（編著）. エイズ予防財団編（宮田 一雄・永易 至文）. 連合出版 2012年 |
|||
| 世界はエイズとどう闘ってきたのか. 宮田 一雄 . ポット出版 2002年 |
|||
| 吉田 正樹 | 東京慈恵会医科大学大学院医学研究科 教授 | ||
| 感染症学 | |||
| An HIV patient with hepatic flare after the initiation of HBV-active antiretroviral therapy. Yoshida M，Hoshina T，Tamura K，Kawano S，Kato T，Sato F，et al. Intern Med 2012；51：1623-6． |
|||
| Comparison of Free and Anonymous Testing for HIV and Sexually Transmitted Infections between the University Hospital and Health Center. Yoshida M，Chiba A，Kawano S，Kato T，Sato F，Horino T，et al. J Infect Chemother. 2012；18：704-708． |
|||
| Evaluation of Short-Time Method with Tetrazolium Salt and Electron Carrier for Measuring Minimal Inhibitory Concentration of Antimicrobial Agents. Yoshida M， Horino T, Nakazawa Y, Yoshikawa K, Hori S. Arch Clin Microbiol. 2017；8：3：47.DOI: 10.4172/1989-8436.100047 |
|||
| 吉村 和久 | 東京都健康安全研究センター 所長 | ||
| ウイルス学・疫学 | |||
| Transmission of COVID-19 in Nightlife, Household, and Health Care Settings in Tokyo, Japan, in 2020. Imamura Takeaki, Aika Watanabe, Yusuke Serizawa, Manami Nakashita, Mayuko Saito, Mayu Okada, Asamoe Ogawa, Yukiko Tabei, Yoshiko Soumura, Yoko Nadaoka, Naoki Nakatsubo, Takashi Chiba, Kenji Sadamasu, Kazuhisa Yoshimura, Yoshihiro Noda, Yuko Iwashita, Yuji Ishimaru, Naomi Seki, Kanako Otani, Tadatsugu Imamura, Matthew Myers Griffith, Kelly DeToy, Motoi Suzuki, Michihiko Yoshida, Atsuko Tanaka, Mariko Yauchi, Tomoe Shimada, Hitoshi Oshitani. JAMA Netw Open. 6(2): e230589. (2023) |
|||
| Identification of SARS-CoV-2 Mpro inhibitors containing P1’ 4-fluorobenzothiazole moiety highly active against SARS-CoV-2. Nobuyo Higashi-Kuwata, Kohei Tsuji, Hironori Hayashi, Haydar Bulut, Maki Kiso, Masaki Imai, Hiromi Ogata-Aoki, Takahiro Ishii, Takuya Kobayakawa, Kenta Nakano, Nobutoki Takamune, Naoki Kishimoto, Shin-ichiro Hattori, Debananda Das, Yukari Uemura, Yosuke Shimizu, Manabu Aoki, Kazuya Hasegawa, Satoshi Suzuki, Akie Nishiyama, Junji Saruwatari, Yukiko Shimizu, Yoshikazu Sukenaga, Yuki Takamatsu, Kiyoto Tsuchiya, Kenji Maeda, Kazuhisa Yoshimura, Shun Iida, Seiya Ozono, Tadaki Suzuki, Tadashi Okamura, Shogo Misumi, Yoshihiro Kawaoka, Hirokazu Tamamura, Hiroaki Mitsuya. Nat Commun. 14: 1076. (2023) |
|||
| The SARS-CoV-2 spike S375F mutation characterizes the Omicron BA.1 variant. Izumi Kimura, Daichi Yamasoba, Hesham Nasser, Jiri Zahradnik, Yusuke Kosugi, Jiaqi Wu, Kayoko Nagata, Keiya Uriu, Yuri L. Tanaka, Jumpei Ito, Ryo Shimizu, Toong Seng Tan, Erika P. Butlertanaka, Hiroyuki Asakura, Kenji Sadamasu, Kazuhisa Yoshimura, Takamasa Ueno, Akifumi Takaori-Kondo, Gideon Schreiber, the Genotype to Phenotype Japan (G2P-Japan) Consortium, Mako Toyoda, Kotaro Shirakawa, Takashi Irie, Akatsuki Saito, So Nakagawa, Terumasa Ikeda, Kei Sato. iScience. 25(12):105720.(2022) |
|||
| 渡瀬 博俊 | 中央区保健所 所長 | ||
| 公衆衛生 | |||
| Geospatial analysis of tuberculosis in Tokyo. Hirotoshi Watase , Yoshiko Nakanishi. Kekkaku 2006 Jul;81(7):481-5. |
|||
| 地域医療資源が下部尿路系癌の死亡状況に与える影響の検討. 渡瀬 博俊, 石川 晃. 日本泌尿器科学会雑誌 2006 年 97 巻 4 号 p. 625-629 |
|||
| 前立腺生検の穿刺パターンとがん採取率のシミュレーションによる評価. 渡瀬 博俊. 日本がん検診・診断学会誌 18 (4) 356-359, 2011 |
|||
